Body Mass Index Enhances the Associations Between Plasma Glucose and Mortality in Patients with Acute Coronary Syndrome

References

• Avanzini F, Mafrici A, Riva E., et al. A multicenter observational study on the management of hyperglycemia in patients with acute coronary syndrome. Nutr Metab Cardiovasc Dis. 2015;25(10):916–923. doi:10.1016/j.numecd.2015.07.007
   Web of Science ®Google Scholar
• Lee TF, Burt MG, Heilbronn LK, et al. Relative hyperglycemia is associated with complications following an acute myocardial infarction: a post hoc analysis of HI-5 data. Cardiovasc Diabetol. 2017;16(1):157. doi:10.1186/s12933-017-0642-3
   PubMed Web of Science ®Google Scholar
• Gu J, Pan JA, Fan YQ, et al. Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus. Cardiovasc Diabetol. 2018;17(1):96. doi:10.1186/s12933-018-0739-3
   Web of Science ®Google Scholar
• Zheng J, Cheng J, Wang T, et al. Does HbA1c level have clinical implications in diabetic patients undergoing coronary artery bypass grafting? A systematic review and meta-analysis. Int J Endocrinol. 2017;2017:1537213. doi:10.1155/2017/1537213
   Web of Science ®Google Scholar
• Kosiborod M. Hyperglycemia in acute coronary syndromes from mechanisms to prognostic implications. Endocrinol Metab Clin North Am. 2018;47(1):185–202. doi:10.1016/j.ecl.2017.11.002
   Web of Science ®Google Scholar
• Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metabolism. 2019;92:98–107. doi:10.1016/j.metabol.2018.10.011
   PubMed Web of Science ®Google Scholar
• Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293–302. doi:10.1038/nrendo.2014.29
   PubMed Web of Science ®Google Scholar
• Collet J-P, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–1367. doi:10.1093/eurheartj/ehaa575
   PubMed Web of Science ®Google Scholar
• Mansour AA, Wanoose HL. Acute phase hyperglycemia among patients hospitalized with acute coronary syndrome: prevalence and prognostic significance. Oman Med J. 2011;26(2):85–90. doi:10.5001/omj.2011.22
   Google Scholar
• Bhupathiraju SN, Hu FB. Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications. Circ Res. 2016;118(11):1723–1735. doi:10.1161/CIRCRESAHA.115.306825
   PubMed Web of Science ®Google Scholar
• Li W, Katzmarzyk PT, Horswell R, et al. HbA1c and all-cause mortality risk among patients with type 2 diabetes. Int J Cardiol. 2016;202:490–496. doi:10.1016/j.ijcard.2015.09.070
   PubMed Web of Science ®Google Scholar
• van Munster SN, van der Graaf Y, de Valk HW, et al. Effect modification in the association between glycated haemoglobin and cardiovascular disease and mortality in patients with type 2 diabetes. Diabetes Obes Metab. 2017;19(3):320–328. doi:10.1111/dom.12820
   Google Scholar
• Liu L, Chen X, Liu Y, et al. The association between fasting plasma glucose and all- cause and cause- specific mortality by gender: the rural Chinese cohort study. Diabetes Metab Res Rev. 2019;35(4):e3129. doi:10.1002/dmrr.3129
   Web of Science ®Google Scholar
• Paolisso P, Foà A, Bergamaschi L, et al. Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA. Cardiovasc Diabetol. 2021;20(1):192. doi:10.1186/s12933-021-01384-6
   PubMed Web of Science ®Google Scholar
• Paolisso P, Foà A, Bergamaschi L, et al. Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA. Cardiovasc Diabetol. 2021;20(1):33. doi:10.1186/s12933-021-01222-9
   PubMed Web of Science ®Google Scholar
• Marfella R, Sasso FC, Siniscalchi M, et al. Peri-procedural tight glycemic control during early percutaneous coronary intervention is associated with a lower rate of in-stent restenosis in patients with acute ST-elevation myocardial infarction. J Clin Endocrinol Metab. 2012;97(8):2862–2871. doi:10.1210/jc.2012-1364
   Web of Science ®Google Scholar
• Lavie CJ, Pandey A, Lau DH, et al. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise. J Am Coll Cardiol. 2017;70(16):2022–2035. doi:10.1016/j.jacc.2017.09.002
   PubMed Web of Science ®Google Scholar
• Kachur S, Lavie CJ, de Schutter A, et al. Obesity and cardiovascular diseases. Minerva Med. 2017;108(3):212–228. doi:10.23736/S0026-4806.17.05022-4
   PubMed Web of Science ®Google Scholar
• Gast KB, Tjeerdema N, Stijnen T, et al. Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS One. 2012;7(12):e52036. doi:10.1371/journal.pone.0052036
   PubMed Web of Science ®Google Scholar
• Koliaki C, Liatis S, Obesity KA. Cardiovascular disease: revisiting an old relationship. Metabolism. 2019;92:98–107.
   PubMed Web of Science ®Google Scholar
• Kawashiri MA, Nakanishi C, Tsubokawa T, et al. Impact of enhanced production of endogenous heme oxygenase-1 by pitavastatin on survival and functional activities of bone marrow-derived mesenchymal stem cells. J Cardiovasc Pharmacol. 2015;65(6):601–606. doi:10.1097/FJC.0000000000000231
   Web of Science ®Google Scholar
• Berglund L, Riserus U, Hambraeus K. Repeated measures of body mass index and waist circumference in the assessment of mortality risk in patients with myocardial infarction. Ups J Med Sci. 2019;124(1):78–82. doi:10.1080/03009734.2018.1494644
   PubMed Web of Science ®Google Scholar
• Coutinho T, Goel K, Corrêa de Sá D, et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol. 2011;57(19):1877–1886. doi:10.1016/j.jacc.2010.11.058
   Web of Science ®Google Scholar